Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BIONTECH | 5 | 13 | +0,22 % | ||
| MODERNA | 1 | 16 | +0,49 % | ||
| ALLOGENE THERAPEUTICS | 1 | 6 | -1,92 % | ||
| GERON | 1 | - | +4,05 % | ||
| OMEROS | 1 | - | +3,90 % | ||
| MEIRAGTX | 1 | - | -5,95 % | ||
| BIOGEN | - | 54 | -0,43 % | ||
| AMGEN | - | 27 | +0,44 % | ||
| INCYTE | - | 25 | +0,20 % | ||
| REGENERON PHARMACEUTICALS | - | 22 | -0,80 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09:30 | ALARMSTUFE ROT bei Biontech: Was sich hinter den Kulissen tut - Was Sie vor Montag noch wissen müssen | Hebelschein-Spekulant | |||
| 00:26 | Geron Corporation (GERN) Appoints Timothy Williams as EVP, Chief Legal Officer | 5 | Insider Monkey | ||
| 00:26 | Allogene Therapeutics (ALLO): 10 Best Growth Stocks Under $10 to Invest In | 3 | Insider Monkey | ||
| 00:26 | Here is Why MeiraGTx Holdings (MGTX) is One of the Best Growth Stocks Under $10 | 2 | Insider Monkey | ||
| Sa | Omeros: Wie eine Fair-Value-Analyse den 74-%-Ausbruch der Biotech-Aktie vorhersagte | 3 | Investing.com Deutsch | ||
| Sa | Curevac verklagt US-Konzern Moderna wegen Patentverletzungen | 74 | manager-magazin.de | ||
| Sa | Psychiatrie-Revolution? Emyria Limited baut globale Service-Schiene für Sponsoren wie Eli Lilly und Compass Pathways aus | Small- & Micro Cap Investment | |||
| Fr | CureVac sues Moderna for patent infringement over COVID-19 vaccines | 18 | Reuters | ||
| Fr | CureVac sues Moderna over mRNA vaccine patents | 12 | Investing.com | ||
| Fr | CureVac verklagt Moderna wegen Patentverletzung bei mRNA-Impfstoffen | 25 | Investing.com Deutsch | ||
| Fr | Biogen: BofA erhöht Kursziel wegen stabilem Kerngeschäft auf 200 US-Dollar | 3 | Investing.com Deutsch | ||
| Fr | BofA raises Biogen stock price target to $200 on base business | 3 | Investing.com | ||
| Fr | Ultragenyx Pharmaceutical Inc.: Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 2 | GlobeNewswire (USA) | ||
| Fr | Intellia to report Phase 3 CRISPR gene editing trial results Monday | 39 | Investing.com | ||
| Fr | Intellia Therapeutics, Inc.: Intellia Therapeutics to Report Topline Data from Global Phase 3 HAELO Clinical Trial of Lonvoguran Ziclumeran in Hereditary Angioedema on April 27, 2026 | 32 | GlobeNewswire (USA) | ||
| Fr | Gericht in Delaware weist Klage von Tesaro gegen AnaptysBio ab | 1 | Investing.com Deutsch | ||
| Fr | Delaware court dismisses Tesaro breach claim against AnaptysBio | 1 | Investing.com | ||
| Fr | AnaptysBio, Inc.: Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro's Anticipatory Breach Claim | 487 | GlobeNewswire (Europe) | Ruling preserves current contracted royalty rates and rejects Tesaro's request for any royalty reductionTrial to adjudicate Anaptys' contract claims and right to seek reversion of Jemperli against... ► Artikel lesen | |
| Fr | NewAmsterdam Pharma Co N.V. - 8-K, Current Report | - | SEC Filings | ||
| Fr | Eton Pharmaceuticals (ETON) Appoints Judith M. Matthews as New CFO | 1 | Insider Monkey |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.